Dexcom | DXCM - Loan Capital



Dexcom reported $1.24B in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Abbott USD 12.93B 194M Jun/2025
Align Technology USD 0 0 Dec/2024
AtriCure USD 61.86M 0 Jun/2025
Avanos Medical USD 95.7M 2.3M Jun/2025
Baxter International USD 9.41B 962M Mar/2025
Becton, Dickinson and Co. USD 17.53B 135M Jun/2025
Boston Scientific USD 10.53B 1.56B Mar/2025
Cooper Companies USD 2.43B 96.1M Jul/2025
Dexcom USD 1.24B 56.7M Jun/2025
Edwards Lifesciences USD 597.8M 100K Mar/2025
Globus Medical USD 173K 84K Jun/2025
Hologic USD 2.51B 37.5M Jun/2025
Insulet USD 939M 673.3M Jun/2025
Integra LifeSciences USD 1.23B 3.7M Jun/2025
J&J USD 38.36B 7.7B Mar/2025
Masimo USD 598.7M 37.3M Jun/2025
Medtronic USD 25.64B 1.66B Apr/2025
Merit Medical Systems USD 731.8M 1.12M Jun/2025
Roche Holding CHF 32.1B 1.94B Dec/2024
Solventum Corp 7.82B 2M Jun/2025
Stryker USD 14.83B 446M Jun/2025
Tandem Diabetes Care USD 309.15M 4.46M Jun/2025
Teleflex USD 1.8B 5.68M Jun/2025
West Pharmaceutical Services USD 202.6M 0 Jun/2025
Zimmer Biomet Holdings USD 6.75B 176.2M Jun/2025